Retracted Prostaglandin E2 reduces swine myocardial ischemia reperfusion injury via increased endothelial nitric oxide synthase and vascular endothelial growth factor expression levels

Key Points

• Myocardial ischemia reperfusion injury was reportedly reduced through prostaglandin E2 administration, indicating potential cardiac benefits.
• Key metrics noted increases in endothelial nitric oxide synthase and vascular endothelial growth factor expression levels.
• Observational analysis originally indicated that prostaglandin E2 could improve outcomes in swine with induced ischemia.
• Retraction highlights the necessity for caution in interpreting these findings and further validation is required.